medline.ch Onkologie Gynäkologische Tumoren

	Switching ahead of progression: Insights from the SERENA-6 trial on targeting emerging ESR1 mutations in advanced HR+/HER2- breast cancer. Med Tolosa P, Montes J, Ciruelos E. PMID: 40945504 [PubMed - in process]
	Advancements in breast cancer therapy: Integrating AI tools for drug discovery and clinical trials. Comput Biol Med Pandey V, Verma P, Natesan G, Chaube U. PMID: 40945222 [PubMed - as supplied by publisher]
	Quantification of tumor heterogeneity based on fractal dimension for predicting the response to neoadjuvant chemotherapy in triple-negative breast cancer. Eur J Radiol Guo J, Liu Y, Ren W, Zheng Y, Ren T, Ma J, Zhao S. PMID: 40945207 [PubMed - as supplied by publisher]
	Palbociclib treatment in patients with HR+/HER2- advanced or metastatic breast cancer and visceral metastasis: A systematic literature review. Breast Radosa JC, Cobo SL, Dzieran J, Glastetter E, Chen C, Lingohr-Smith M, Pasupuleti V, Brufsky A. PMID: 40945169 [PubMed - as supplied by publisher]
	Design, synthesis and molecular modelling studies of bile acid-curcumin conjugates as potential antiproliferative agents for breast cancer. Bioorg Med Chem Rathod NV, Dalai P, Agrawal-Rajput R, Mishra S. PMID: 40944993 [PubMed - as supplied by publisher]
	Tumor microenvironment response to neoadjuvant therapy in breast cancer: insights from single-cell and spatial omics. Med Oncol Wu Q, Yang J, Zhang D, Xu H, Yu Y, Zheng Y. PMID: 40944804 [PubMed - in process]
	Effect of eight different acupuncture and moxibustion therapies on breast cancer-related lymphedema: a Bayesian network meta-analysis. Support Care Cancer Zhang D, Zhao X, Li H, Chen W, Liu C. PMID: 40944772 [PubMed - in process]
	Long-term impact of stressful life events on breast cancer risk: A 36-year genetically informed prospective study in the Finnish Twin Cohort. Int J Cancer Azzi E, Bode H, Palviainen T, Hukkanen M, Ollikainen M, Kaprio J. PMID: 40944570 [PubMed - as supplied by publisher]
	Influence of Site, Surgery, and BMI Binary Classification on Positioning Errors in Radiotherapy for Breast Cancer Patients: A Retrospective Study. Cancer Rep (Hoboken) Wan B, Huan FK, Ge YD, Zhao RA, Zheng YT, Liang M, Zhang YX, Zhang W, Hou L, Zhang Y, Wang HK. PMID: 40944424 [PubMed - in process]
	Targeting Lymphedema in Overweight Breast Cancer Survivors: A Pilot Randomized Controlled Trial of Diet and Exercise Intervention. Nutrients Ruiz-Molina Y, Padial M, Martín-Bravo MDM, García-Olivares M, Porras N, Chicharro A, Mora-Robles J, González-Jiménez A, Sasso CV, Olveira G. PMID: 40944158 [PubMed - in process]
	Is There a Therapeutic Benefit of Axillary Surgery in Non-Metastatic Breast Cancer? A SEER Cohort Database Study. J Clin Med Sabah J, Marouk A, Molière S, Lodi M. PMID: 40944072 [PubMed - in process]
	Explainable Machine Learning for the Early Clinical Detection of Ovarian Cancer Using Contrastive Explanations. J Clin Med Kucukakcali Z, Cicek IB, Akbulut S. PMID: 40943960 [PubMed - in process]
	Microbial Signatures in Breast Cancer: Exploring New Potentials Across Body Niches. Int J Mol Sci Wong AYW, Bicchieraro G, Palumbo I, Ciabattoni A, Aristei C, Spaccapelo R. PMID: 40943572 [PubMed - in process]
	Molecular Mechanisms of Estrogens in the Induction of Epithelial-to-Mesenchymal Transition and Metastasis in Breast Cancer. Int J Mol Sci Jiménez-Salazar J, Garcia-Melo L, Batina N, Alarcón-Aguilar A, Luna-López A, Hernández-Garcés P, Damián-Ferrara R, Damián-Matsumura P. PMID: 40943509 [PubMed - in process]
	Protease-Activated Receptor F2R Is a Potential Target for New Diagnostic/Prognostic and Treatment Applications for Patients with Ovarian Cancer. Int J Mol Sci Khetan R, Lokman NA, Eldi P, Price ZK, Oehler MK, Brooks DA, Blencowe A, Garg S, Ricciardelli C, Albrecht H. PMID: 40943451 [PubMed - in process]
	Is Radiographic Aftercare Obsolete? How Testing Positive for ctDNA Can Be a Precedent for Late Relapse, Even in Low-Risk Hormone-Receptor-Positive Breast Cancer. Int J Mol Sci Pfister K, Huesmann S, Fink A, Friedl TWP, Mergel F, Schäffler HP, Hartkopf A, Lukac S, Veselinovic K, Mehmeti F, Campbell N, Pipinikas C, Deininger K, Beer A, Lorenz S, Beer M, Wiesmüller L, Janni W, Heublein S, Rack B. PMID: 40943419 [PubMed - in process]
	The OvarianTagâ„¢ Biomarker Panel Emerges as a Prognostic Tool to Guide Clinical Decisions in Cisplatin-Based Treatment of Epithelial Ovarian Cancer. Int J Mol Sci Braga LDC, Amaral LRD, Villar Delfino PH, Andrade NR, de Oliveira Salles PG, da Silva Filho AL, Bertarini PLL, da Silva Ramos APÁ, Gomes MS, Silva Lopes LM. PMID: 40943317 [PubMed - in process]
	[18F]FDG PET/CT Radiomics in Untreated Breast Carcinoma: A Review of the Current State and Future Directions. Diagnostics (Basel) Mitoi A, Mititelu RM, Medar C, Constantin C, Bolocan VO, Mate. PMID: 40941718 [PubMed - in process]
	Clinical Evaluation of a Multi-Omic Diagnostic Model for Early-Stage Ovarian Cancer Detection. Diagnostics (Basel) Law RA, Giles BM, Culp-Hill R, Radnaa E, Goldberg M, Nichols CM, Wong M, Hansen C, Hill C, Eurich K, Prendergast E, Behbakht K, Bitler BG, Jeter A, Fa VS, White JR, Elias K, McElhinny A. PMID: 40941712 [PubMed - in process]
	Enhanced Breast Cancer Diagnosis Using Multimodal Feature Fusion with Radiomics and Transfer Learning. Diagnostics (Basel) Maruf NA, Basuhail A, Ramzan MU. PMID: 40941663 [PubMed - in process]

Artikel 1 - 20 / 314349

Seite 1 von 15718

Suchbegriffe

Benutzen Sie englische Suchbegriffe für Ihre Suche in medline.ch.

Übersetzungsproblem?

mehr >>



		Zeitfenster

	Mediscope AG E-mail: info@mediscope.ch
	Disclaimer \| Datenschutzerklärung / Privacy Policy \| Werbung